Kyosuke Seto
General Partner at Garnet Capital
Tokyo, Tokyo
Kyosuke Seto, General Partner at Garnet Capital is an active investor based in Tokyo, Tokyo. This profile covers what Kyosuke Seto backs, at which stage, and how founders can reach out in 2026.
Kyosuke Seto is a General Partner at Garnet Capital.
- Investor type
- VC
- Stages
- Early Stage Venture
- Invests in
- SaaS & Enterprise
- Location
- Tokyo, Tokyo
- Typical check
- $500K
How to reach Kyosuke Seto
Angels and operators like Kyosuke Seto reply to specific, personalized notes that show real traction, not mass blasts. Build a verified list, write a note that fits their thesis, and track replies, all on Round Funded.
Connect with Kyosuke Seto
About this profile
This profile is part of Round Funded, an investor database and outreach platform for founders. It covers 60,000+ active VCs, angels, family offices and accelerators with verified contacts, lets you send pitches from your own Gmail, and includes a free Data Room for your raise.
Frequently Asked Questions
What does Kyosuke Seto invest in?
Kyosuke Seto invests in SaaS & Enterprise, typically at Early Stage Venture. Match your sector and stage, then reach out with a personalized pitch.
What stage does Kyosuke Seto invest at?
Kyosuke Seto typically invests at Early Stage Venture. Lead with traction that fits the stage when you reach out.
What is Kyosuke Seto's typical check size?
Kyosuke Seto typically writes checks around $500K. Use it as a signal for whether your raise fits their stage.
How do I contact Kyosuke Seto?
Unlock Kyosuke Seto's verified email on Round Funded and send a personalized pitch. We surface only deliverable contacts so your outreach lands.
What is Round Funded?
Round Funded is an investor database and outreach platform for startup founders. It lists 60,000+ active investors with verified contacts, filtered to recent investment activity, and lets founders send personalized pitches from their own Gmail, track replies, and share a free Data Room. Round+ starts at $99 per month with a 3-day trial.